Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Study starts
You may also be interested in...
Financings In Brief
Cancer Genetics plans initial public offering. Mitralign raises $35 million for valve repair device. More financings.
Merit Medical Gains Embolic Microsphere Line With $96 Mil. BioSphere Buy
Merit Medical Systems is augmenting its interventional radiology business with the $96 million acquisition of embolic microsphere marketer BioSphere Medical, announced May 13
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”